Investment analysts at StockNews.com started coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Up 2.5 % EGRX opened at $3.43 on Wednesday. The company’s 50-day moving […]
StockNews.com Upgrades Eagle Pharmaceuticals (NASDAQ:EGRX) to Buy theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Eagle Pharmaceuticals (NASDAQ:EGRX) Releases FY 2023 Earnings Guidance themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Eagle Pharmaceuticals (NASDAQ:EGRX) Issues FY23 Earnings Guidance theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report) saw a significant growth in short interest in July. As of July 15th, there was short interest totalling 680,200 shares, a growth of 14.6% from the June 30th total of 593,600 shares. Currently, 6.0% of the shares of the company are short sold. Based on an average […]